Want to see HK:1612 full AI Analyst Report?
1612 Stock Chart & Stats
HK$0.83
<HK$0.01(1.28%)
At close: 4:00 PM EST
HK$0.83
<HK$0.01(1.28%)
Day’s Range― - ―
52-Week RangeHK$0.69 - HK$1.32
Previous CloseN/A
Volume194.00K
Average Volume (3M)785.93K
Market Cap
HK$468.67M
Enterprise ValueHK$433.22M
Total Cash (Recent Filing)HK$250.87M
Total Debt (Recent Filing)HK$177.42M
Price to Earnings (P/E)4.4
Beta0.65
Next Earnings
Aug 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield7.04%
Share Statistics
EPS (TTM)0.16
Shares Outstanding660,098,800
10 Day Avg. Volume481,400
30 Day Avg. Volume785,933
Financial Highlights & Ratios
PEG Ratio0.11
Price to Book (P/B)0.81
Price to Sales (P/S)0.57
P/FCF Ratio9.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.12
Revenue Forecast (FY)HK$1.17B
Bulls Say, Bears Say
Bulls Say
Revenue Re-accelerationSustained multi-year revenue re-acceleration across 2023–2025 demonstrates strengthening demand and market traction in core respiratory and infection-control products. This trend supports durable top-line expansion and provides a platform for scaling fixed-cost leverage and product distribution over the next several quarters.
Improved Margins And ProfitabilityMargin expansion to ~35% gross and ~11% net in 2025 indicates stronger pricing, mix, or cost control, which enhances earnings resilience. Higher sustainable margins improve cash generation potential and give management more flexibility for reinvestment, R&D, or dividend support over a medium-term horizon.
Manageable LeverageA modest debt-to-equity (~0.27) provides room to fund growth initiatives or buffer operational cycles without heavy interest burden. Manageable leverage preserves balance-sheet optionality for strategic investments or working-capital needs and reduces refinancing risk in a 2–6 month operational planning window.
Bears Say
Weak Cash ConversionLow FCF conversion (~32% of net income) and year-over-year volatility constrain the company's ability to self-fund capex, acquisitions, or reliably sustain dividends. Persistent weak conversion raises funding dependence and increases sensitivity to working-capital swings across upcoming quarters.
Earnings Volatility / Prior LossHistory of a 2022 loss and uneven results since implies earnings are still cyclical or execution-dependent. This structural volatility complicates forecasting and heightens the risk that margins or profits could reverse if demand or input-cost trends deteriorate, affecting strategic planning.
Rising Debt TrendAn increasing debt-to-equity trend over successive years lowers balance-sheet conservatism and reduces headroom for shocks. If leverage continues to rise, interest and covenant risk could constrain capital allocation choices and heighten refinancing sensitivity over the medium term.
Vincent Medical Holdings Limited News
1612 FAQ
What was Vincent Medical Holdings Limited’s price range in the past 12 months?
Vincent Medical Holdings Limited lowest stock price was HK$0.69 and its highest was HK$1.32 in the past 12 months.
What is Vincent Medical Holdings Limited’s market cap?
Vincent Medical Holdings Limited’s market cap is HK$468.67M.
When is Vincent Medical Holdings Limited’s upcoming earnings report date?
Vincent Medical Holdings Limited’s upcoming earnings report date is Aug 26, 2026 which is in 23 days.
How were Vincent Medical Holdings Limited’s earnings last quarter?
Vincent Medical Holdings Limited released its earnings results on Mar 25, 2026. The company reported HK$0.082 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.082.
Is Vincent Medical Holdings Limited overvalued?
According to Wall Street analysts Vincent Medical Holdings Limited’s price is currently Overvalued.
Does Vincent Medical Holdings Limited pay dividends?
Vincent Medical Holdings Limited pays a Quarterly dividend of HK$0.026 which represents an annual dividend yield of 7.04%. See more information on Vincent Medical Holdings Limited dividends here
What is Vincent Medical Holdings Limited’s EPS estimate?
Vincent Medical Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vincent Medical Holdings Limited have?
Vincent Medical Holdings Limited has 660,098,800 shares outstanding.
What happened to Vincent Medical Holdings Limited’s price movement after its last earnings report?
Vincent Medical Holdings Limited reported an EPS of HK$0.082 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.998%.
Which hedge fund is a major shareholder of Vincent Medical Holdings Limited?
Currently, no hedge funds are holding shares in HK:1612
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Vincent Medical Holdings Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
116.00%
12-Months-Change
Fundamentals
Return on Equity
7.04%
Trailing 12-Months
Asset Growth
27.38%
Trailing 12-Months
Company Description
Vincent Medical Holdings Limited
Vincent Medical Holdings Limited is an investment holding company engaged in the comprehensive process of designing, manufacturing, marketing, and distributing medical devices. Its operations are bifurcated into two main business models: providing products for other companies (Original Equipment Manufacturing, or OEM) and selling goods under its own proprietary labels (Original Brand Manufacturing). For its OEM clientele, the company specializes in developing respiratory care products, disposable components for imaging contrast media power injectors, and a range of orthopedic and rehabilitation solutions. Its extensive respiratory portfolio encompasses humidification systems, nCPAP interface systems, dedicated respiratory care units, electronic air-oxygen blenders, and anesthesia systems. In the orthopedic and rehabilitation sector, Vincent Medical offers various adjustable braces engineered for post-injury or post-surgical support, protection, and recovery of musculoskeletal areas. The company also pioneers the development of robotic hand training devices. Under its own brand names, including Inspired Medical, Hand of Hope, and Hypnus, Vincent Medical Holdings Limited distributes its offerings across a wide international market. Key regions include the People's Republic of China, the United States, the Netherlands, Australia, and Japan. Established in 1997 and headquartered in Hung Hom, Hong Kong, the company functions as a subsidiary of Vincent Raya International Limited.
Technical Analysis
Peijia Medical Ltd.
―
Acotec Scientific Holdings Limited
―
AK Medical Holdings Ltd.
―
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H
―
MicroPort NeuroTech Limited
―